Fedor Nikulenkov, Ph.D.
Researcher, Lumír Krejčí Research Group
Office: bldg. B07/307
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7365 |
---|---|
E‑mail: |
Total number of publications: 17
2019
-
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome
CLINICAL EPIGENETICS, year: 2019, volume: 11, edition: 1, DOI
2018
-
Pyrazolotriazines as inhibitors of nucleases
Publisher: Japan Patent Office, state: Japan, patent's number: JP 6313906, year: 2018
-
Pyrazolotriazines as inhibitors of nucleases
Publisher: USPTO, state: United States of America, patent's number: US 9969741 B2, year: 2018
2017
-
Pyrazolotriazines as inhibitors of nucleases
Publisher: European Patent Office, state: Germany, patent's number: EP2957562, year: 2017
-
Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation
Molecular Cancer Therapeutics, year: 2017, volume: 16, edition: 9, DOI
2014
-
Exploring synthetic lethal interaction between Checkpoint Kinase 1(CHK1) and DNA replication stress
Year: 2014, type: Appeared in Conference without Proceedings
2013
-
Lif1 SUMOylation and its role in non-homologous end-joining
Nucleic Acids Research, year: 2013, volume: 41, edition: 10, DOI